Make comprehensive risk assessment
part of your routine practice

Your patient may be eligible for two or more geneTypes.
Review the eligibility criteria for each below.

Patient Eligibility

ages 30* through 85

Men may be eligible for as many as 7 tests
Women may be eligible for as many as 8 tests
*dependent on patient personal medical history, sex and age; cancer assessments are available starting at 30, cardio and metabolic starting at age 40

Proactive Healthcare

A wellness visit general health check is an opportunity to consider your patient’s ongoing health and motivate them to maintain healthy lifestyles and compliant screening practices.

Let geneType be a tool to enable preventative care discussions with your patient.

Engage your patient’s understanding of their personal risk of disease by communicating:

Value in screening compliance (based on current screening guidelines)
Available supplemental screening options
Available risk reducing medication options
Available lifestyle modifications to reduce disease-risk (e.g. smoking cessation, improved nutrition, reducing alcohol consumption, increased physical activity)

Incorporate geneType into your patient’s next wellness visit

While many risk assessments focus on family history and heritable genetic markers, geneType Multi-Risk Test goes beyond this by incorporating clinical, familial and genetic factors that affect disease risk.

Your patient’s risk assessment can then be used to develop a personalized, preventative health plan that includes screening, risk-reducing medication and/or lifestyle interventions.

Actionable Clinical Insights

GeneType Reports reflect the tests that you requested on your patient’s clinical questionnaire. Reports are structured to make the results easy to interpret and communicate to your patients.

Reports include:

Snapshot of your patient’s absolute risk scores
Interpretation of what their risk scores mean in the context of current guidelines
Polygenic risk score indicating your patient’s “baseline” risk for disease
Information about modifiable risk factors
The types of disease-specific screening and risk-reduction interventions available to your patient

Contact us for more information.

GeneType testing is simple

Step 1

Register as a provider; our team will provide clinical education and other resources as needed.

GeneType will send kits to your clinic to have on hand.

Step 2

Discuss geneType with your patient.

Would geneType help them qualify for additional risk reduction strategies?

Step 3

Complete the Test Requisition form, collect a sample from the patient in the saliva tube provided and return both to geneType.

You will have the option to use a paper requisition, or a secure, compliant portal to complete the ordering process.

Step 4

Leave the rest to us.

GeneType will notify you when your patient’s results are ready.

You will have the option to request a consult with a genetic counsellor, whether to review your patient’s results and/or to follow-up with your patient, as needed.

register as a geneType provider

Patient out-of-pocket costs

geneType is a self-pay test. Patient is billed directly.

FSA/HSA may be used to pay for the test.

The geneType suite can be purchased for $349.

Take the first step towards personalized, preventative healthcare

Learn more about each individual risk assessment included within the Multi-Suite.

Breast Cancer

GeneType provides lifetime and 5-year risk scores for breast cancer

providers

Colorectal Cancer

GeneType provides lifetime and 10-year risk scores for colorectal cancer

providers

Ovarian Cancer

GeneType provides lifetime and 10-year risk scores for ovarian cancer

providers

Coronary Artery Disease

GeneType provides a 10-year risk score for coronary artery disease

providers

Type 2 Diabetes

GeneType provides an 8-year risk score for type 2 diabetes

providers

Prostate Cancer

GeneType provides lifetime and 5-year risk scores for prostate cancer

providers

Pancreatic Cancer

GeneType provides lifetime and 10-year risk scores for pancreatic cancer

Now Available

Melanoma

GeneType provides lifetime and 10-year risk scores for melanoma

Now Available

Atrial Fibrillation

GeneType provides a 10-year risk score for atrial fibrillation

Now Available

Do you have questions?
We have answers.

If your question is not shown here, contact us directly.

Is this test reimbursed by insurance?

This test is not generally covered by insurance. A credit card authorization form will be included in the test kit that lists the payment options. Your patient may use their FSA/HSA to pay for the test as well.